| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ... The Lancet Neurology 16 (8), 661-676, 2017 | 687 | 2017 |
| Tau PET imaging in neurodegenerative tauopathies—still a challenge A Leuzy, K Chiotis, L Lemoine, PG Gillberg, O Almkvist, ... Molecular psychiatry 24 (8), 1112-1134, 2019 | 599 | 2019 |
| Tau PET imaging: present and future directions L Saint-Aubert, L Lemoine, K Chiotis, A Leuzy, E Rodriguez-Vieitez, ... Molecular neurodegeneration 12, 1-21, 2017 | 321 | 2017 |
| Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease E Rodriguez-Vieitez, L Saint-Aubert, SF Carter, O Almkvist, K Farid, ... Brain 139 (3), 922-936, 2016 | 299 | 2016 |
| Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm K Chiotis, L Saint-Aubert, I Savitcheva, V Jelic, P Andersen, M Jonasson, ... European journal of nuclear medicine and molecular imaging 43 (9), 1686-1699, 2016 | 152 | 2016 |
| Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding L Lemoine, A Leuzy, K Chiotis, E Rodriguez-Vieitez, A Nordberg Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10, 232-236, 2018 | 150 | 2018 |
| Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study A Leuzy, K Chiotis, SG Hasselbalch, JO Rinne, A de Mendonça, M Otto, ... Brain 139 (9), 2540-2553, 2016 | 142 | 2016 |
| Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia K Chiotis, L Saint-Aubert, E Rodriguez-Vieitez, A Leuzy, O Almkvist, ... Molecular psychiatry 23 (7), 1666-1673, 2018 | 108 | 2018 |
| Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline M Bucci, K Chiotis, A Nordberg, ... Molecular psychiatry 26 (10), 5888-5898, 2021 | 99 | 2021 |
| Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging NA Murugan, K Chiotis, E Rodriguez-Vieitez, L Lemoine, H Ågren, ... European journal of nuclear medicine and molecular imaging 46, 1369-1382, 2019 | 96 | 2019 |
| Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease E Rodriguez-Vieitez, SF Carter, K Chiotis, L Saint-Aubert, A Leuzy, ... Journal of Nuclear Medicine 57 (7), 1071-1077, 2016 | 80 | 2016 |
| Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework K Chiotis, L Saint-Aubert, M Boccardi, A Gietl, A Picco, A Varrone, ... Neurobiology of aging 52, 214-227, 2017 | 78* | 2017 |
| A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting L Iaccarino, K Chiotis, P Alongi, O Almkvist, A Wall, C Cerami, V Bettinardi, ... Journal of Alzheimer's Disease 59 (2), 603-614, 2017 | 69 | 2017 |
| Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease L Saint-Aubert, O Almkvist, K Chiotis, R Almeida, A Wall, A Nordberg Alzheimer's research & therapy 8, 1-9, 2016 | 68 | 2016 |
| Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology M Jonasson, A Wall, K Chiotis, L Saint-Aubert, H Wilking, M Sprycha, ... Journal of Nuclear Medicine 57 (4), 574-581, 2016 | 68 | 2016 |
| Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer’s disease E Rodriguez-Vieitez, A Leuzy, K Chiotis, L Saint-Aubert, A Wall, ... Journal of Cerebral Blood Flow & Metabolism 37 (2), 740-749, 2017 | 63 | 2017 |
| Role of anthropometric characteristics in idiopathic carpal tunnel syndrome K Chiotis, N Dimisianos, A Rigopoulou, A Chrysanthopoulou, E Chroni Archives of physical medicine and rehabilitation 94 (4), 737-744, 2013 | 53 | 2013 |
| Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease SF Carter, K Chiotis, A Nordberg, E Rodriguez-Vieitez European Journal of Nuclear Medicine and Molecular Imaging 46, 348-356, 2019 | 51 | 2019 |
| Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis A Leuzy, I Savitcheva, K Chiotis, J Lilja, P Andersen, N Bogdanovic, ... European journal of nuclear medicine and molecular imaging 46, 1276-1286, 2019 | 50 | 2019 |
| Concordance and diagnostic accuracy of [11C] PIB PET and cerebrospinal fluid biomarkers in a sample of patients with mild cognitive impairment and Alzheimer's disease A Leuzy, SF Carter, K Chiotis, O Almkvist, A Wall, A Nordberg Journal of Alzheimer's Disease 45 (4), 1077-1088, 2015 | 49 | 2015 |
Elena Rodriguez-Vieitez, PhD, Senior...Karolinska Institutet在 ki.se 的电子邮件经过验证
